FDA reviews depression drugs–Intense or Cautious? WashPost/ NYT/ Herald Wed, 29 Oct 2003 The Washington Post correctly reports: “The association between antidepressants, particularly the selective serotonin reuptake inhibitors (SSRIs), and suicide has been controversial since the first SSRI, Prozac, came on the market in the late 1980s.” But stakeholders in…
NY Times Whitewashes Ritalin Experiment in Preschool Kids Sat, 16 Nov 2002 A story in The New York Times magazine about a controversial government sponsored drug experiment avoids examining the tough issues. Instead, it describes the growing pains of an apparently normal 4 year old boy, Sam, whose parents enrolled…
NYT Pitches New Brain Disorder: “Executive Dysfunction” Tue, 26 Aug 2003 Should the Science section of The New York Times be in the business of promoting the expanded use of psychotropic drugs for unproven non-medical conditions? Today’s Science section of the New York Times includes 2 promotional articles that covertly…
BBC PANORAMA TONIGHT – Taken on Trust – 13 years-Medical Deception Sun, 3 Oct 2004 BBC-Panorama is airing its third in a series of investigative reports about the betrayal of trust in psychiatry, drug manufacturers and government regulators. The first program, The Secret of Seroxat, aired October 13, 2002, revealed…
Advisory Committee tells FDA: strengthen warnings on SSRI drug labels now Wed, 4 Feb 2004 On February 2, more than 60 families and children from all across America testified at a public FDA advisory committee hearing describing (in 2 minutes) how their children suffered drug-induced harm after being prescribed an…
20% Drop in Psych Drugs Prescribed for US Children – WashPost Sat, 8 Oct 2005 The Washington Post reports (below) that prescriptions for antidepressants for children have dropped an unprecedented 20% in the US. A continuing series of substantiated reports and Black Box warnings about an increased risk of suicide,…
Expert FDA Report: SSRI Suicide risk_SF Chronicle / NYT/ NJ Ledger/ AP Fri, 16 Apr 2004 FDA officials have provoked congressional hearings at which they will have to explain, not only why they concealed data linking antidepressants to increased violent and suicidal behavior, and why they covered up a report…
FATAL FLAW Efforts to Overturn SSRI Black Box warning before it has even been implemented Date: Mon, 24 Jan 2005 Even as the Black Box Suicidality Warning on SSRI antidepressant labels have not even been implemented, aggressive efforts are underway by a powerful consortium of medical-pharmaceuticaql self-interest groups – among…
How to earn promotions in pharmaceutical industry Tue, 6 Sep 2005 In the world of pharmaceuticals, careers are made by marketing the worst products that cause the greatest harm. Contact: Vera Hassner Sharav 212-595-8974 XenoPort Appoints Gary D. Tollefson, Former Lilly Executive, to Board Company Snapshot: XNPThttp://www.xenoport.com SANTA CLARA, Calif.,…
Marketing Diseas – NYT /APA invites Soprano-Actress Psychiatrist– Pfizer Spokeswoman to speak at conference Fri, 13 May 2005 The New York times reported how drug companies invent and market a disease in order to ensure a market for newly developed drugs. Under the influence of the pharmaceutical industry, illness does…
Testing Psychotropic Drugs in Children April 30, 2002 David Healy, MD University of Wales College of Medicine April 30th 2002. The background against which this paper is prepared is that in 1997 I organized, chaired and wrote up the recommendations from an International Roundtable Meeting for the British Association for…
To view AHRP news and infomails from 2006, please visit our new site. Infomails Subscribe to AHRP’s infomails At FDA, Graham is still the whistle-blower Loss of Trust: Big Drug Makers See Sales Decline With Their Image War hero’s death in clinical trial follows years of FDA neglect European perspective:…
